Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Unknown 3

Sponsor Class

OTHER 71INDUSTRY 44NIH 7UNKNOWN 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Esophageal Neoplasms 8Breast Neoplasms 5Triple Negative Breast Neoplasms 3Stomach Neoplasms 1Recurrence 1Nasopharyngeal Neoplasms 1IMRT With or Without Concurrent Chemotherapy for Esophageal Cancer 1Esophageal Squamous Cell Carcinoma 1Carcinoma, Squamous Cell 1Adenocarcinoma 1

Interventions

Epirubicin 4Paclitaxel 3Cyclophosphamide 3Carboplatin 3anlotinib 2Capecitabine 2pirarubicin 1lobaplatin 1eribulin 1Zoledronic Acid 1Granulocyte Colony-Stimulating Factor 1Etoposide 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
UNKNOWN × Triple Negative Breast Neoplasms × Paclitaxel × Clear all
NCT03876886 2019-03-21

The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency

ChineseAMS

Phase 3 Unknown
200 enrolled
Breast

Triple Negative Breast Neoplasms

NCT01378533 2011-12-28

The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC

ChineseAMS

Phase 3 Unknown
100 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01276769 2011-11-16

Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer

ChineseAMS

Phase 2 Unknown
80 enrolled
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡